Prognostic value of histopathology, stromal tumor infiltrating lymphocytes (sTILs) and adjuvant chemotherapy (AdjCT) in early stage triple negative breast cancer (TNBC).

被引：0
|
作者：
Leon-Ferre, Roberto Antonio
Polley, Mei-Yin
Liu, Heshan
Gilbert, Judith A.
Cafourek, Victoria
Hillman, David W.
Elkhanany, Ahmed
Akinhanmi, Margaret
Negron, Vivian
Boughey, Judy Caroline
Liu, Minetta C.
Ingle, James N.
Kalari, Krishna R.
Couch, Fergus
Visscher, Daniel W.
Goetz, Matthew P.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Alliance Stat, Rochester, MN USA
[3] Mayo Clin, Ctr Data, Rochester, MN USA
[4] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
533
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).
    Luen, Stephen James
    Salgado, Roberto
    Dieci, Maria Vittoria
    Vingiani, Andrea
    Curigliano, Giuseppe
    Hubbard, Rebekah
    Altamirano, Carlos Castaneda
    Sanchez, Joselyn
    D'Alfonso, Timothy
    Cheng, Esther
    Garcia, Miluska Castillo
    Adams, Sylvia
    Ahmed, Fahad
    Rimm, David L.
    Demaria, Sandra
    Symmans, William Fraser
    Michiels, Stefan
    Loi, Sherene
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer
    Tu, Hengjia
    Zhang, Yuzhuo
    You, Zhixuan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (04):
  • [23] Prognostic impact of tumor infiltrating lymphocytes (TIL's) and stromal-infiltrating lymphocytes (SIL's) in triple negative breast cancer
    Sherwell-Cabello, S.
    Maffuz-Aziz, A.
    Bautista-Pina, V.
    Labastida-Almendaro, S.
    Camacho-Ramirez, D. A.
    Rios-Luna, N. P.
    Rodriguez-Cuevas, S.
    CANCER RESEARCH, 2016, 76
  • [24] Prognostic impact of high stromal tumor-infiltrating lymphocytes (sTIL) in the absence of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in early stage triple negative breast cancer (TNBC).
    Abuhadra, Nour
    Sun, Ryan
    Litton, Jennifer Keating
    Rauch, Gaiane M.
    Thompson, Alastair Mark
    Lim, Bora
    Adrada, Beatriz E.
    Mittendorf, Elizabeth A.
    White, Jason B.
    Ravenberg, Elizabeth
    Damodaran, Senthil
    Candelaria, Rosalind P.
    Arun, Banu
    Ueno, Naoto T.
    Santiago, Lumarie
    Murthy, Rashmi Krishna
    Ibrahim, Nuhad K.
    Symmans, William Fraser
    Moulder, Stacy L.
    Huo, Lei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Investigation of tumor infiltrating Lymphocytes of the Tumor Stroma (sTILs) in triple negative Breast Carcinomas (TNBC) from Sub-Saharan Africa (SAA)
    Bauer, M.
    Fathke, C.
    Stueckrath, K.
    Voigtlander, S.
    Vetter, M.
    Wickenhauser, C.
    Kantelhardt, E.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E94 - E94
  • [26] Impact of body mass index (BMI) on the predictive and prognostic value of stromal tumor-infiltrating lymphocytes (sTIL) in triple-negative breast cancer (TNBC) patients treated with neoadjuvant chemotherapy (NACT)
    Desmedt, Christine
    Richard, Francois
    Jongen, Lynn
    Hamy-Petit, Anne-Sophie
    Wildiers, Hans
    Ardui, Jan
    Punie, Kevin
    Smeets, Ann
    Berteloot, Patrick
    Vergote, Ignace
    Lae, Maricl
    Decroze, Diane
    Meseure, Didier
    Reyal, Fabien
    Biganzoli, Elia
    Neven, Patrick
    Floris, Giuseppe
    CANCER RESEARCH, 2020, 80 (04)
  • [27] Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC)
    Adams, Sylvia
    Goldstein, Lori J.
    Sparano, Joseph A.
    Demaria, Sandra
    Badve, Sunil S.
    ONCOIMMUNOLOGY, 2015, 4 (09): : 1 - 3
  • [28] Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
    Castaneda, Carlos A.
    Mittendorf, Elizabeth
    Casavilca, Sandro
    Wu, Yun
    Castillo, Miluska
    Arboleda, Patricia
    Nunez, Teresa
    Guerra, Henry
    Barrionuevo, Carlos
    Dolores-Cerna, Ketty
    Belmar-Lopez, Carolina
    Abugattas, Julio
    Calderon, Gabriela
    De La Cruz, Miguel
    Cotrina, Manuel
    Dunstan, Jorge
    Gomez, Henry L.
    Vidaurre, Tatiana
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (05): : 387 - 394
  • [29] Prognostic value of tumor: Infiltrating lymphocytes and androgen receptors correlation in triple negative breast cancer.
    Vuger, Ana Tecic
    Separovic, Robert
    Vazdar, Ljubica
    Pavlovic, Mirjana
    Sitic, Sanda
    Sarcevic, Bozena
    Vrbanec, Damir
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Prognostic significance of tumor-infiltrating lymphocytes (TILs) in patients with early-stage triple-negative breast cancer (TNBC) treated with curative resection alone
    Park, J. H.
    Lee, H. J.
    Ahn, J-H.
    Kim, J. E.
    Jung, K. H.
    Gong, G.
    Kim, S-B.
    ANNALS OF ONCOLOGY, 2017, 28
12345